Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taj API appears to be the active pharmaceutical ingredients business/unit of Taj Pharmaceuticals Limited, an India-based pharmaceutical manufacturer focused on small-molecule APIs, intermediates, and related contract manufacturing services. The company markets itself as a large API producer serving generic formulators and pharmaceutical customers worldwide, with a portfolio spanning more than 200 commercialized APIs. Publicly available materials indicate capabilities in cGMP-compliant manufacturing, documentation aligned with ICH expectations, and global export activity across multiple international markets. The broader Taj Pharma group also markets finished-dose generics and branded products, but Taj API is primarily positioned around bulk actives and custom/API manufacturing rather than novel clinical-stage drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taj API.